{
  "paper_id": "139b9a993204af8852fbdb685a455ee770eb481a",
  "metadata": {
    "title": "Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial",
    "coda_data_split": "dev",
    "coda_paper_id": 1377,
    "coda_has_expert_labels": false,
    "subset": "biorxiv_medrxiv"
  },
  "abstract": [
    {
      "original_text": "Manuscript word count: Key points 63; Abstract 349; Full text 2924 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
      "sentences": [
        [
          {
            "segment_text": "Manuscript word count : Key points 63 ; Abstract 349 ; Full text 2924 All rights reserved .",
            "crowd_label": "other"
          }
        ],
        [
          {
            "segment_text": "No reuse allowed without permission .",
            "crowd_label": "other"
          }
        ],
        [
          {
            "segment_text": "author/funder , who has granted medRxiv a license to display the preprint in perpetuity .",
            "crowd_label": "other"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "3",
    "segment_num": "3",
    "token_num": "39"
  }
}